Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains. |
Kariya M, Mori S, Eizuru Y |
2000 |
Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance. |
De Bolle L, Manichanh C, Agut H, De Clercq E, Naesens L |
2004 |
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs. |
Davis MG, Wilson JE, VanDraanen NA, Miller WH, Freeman GA, Daluge SM, Boyd FL, Aulabaugh AE, Painter GR, Boone LR |
1996 |
Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone. |
Souza TM, De Souza MC, Ferreira VF, Canuto CV, Marques IP, Fontes CF, Frugulhetti IC |
2008 |
Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. |
Yang G, Dutschman GE, Wang CJ, Tanaka H, Baba M, Anderson KS, Cheng YC |
2007 |
Main properties of duck hepatitis B virus DNA polymerase: comparison with the human and woodchuck hepatitis B virus DNA polymerases. |
Fourel I, Hantz O, Cova L, Allaudeen HS, Trepo C |
1987 |
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide. |
Loutfy MR, Raboud JM, Montaner JS, Antoniou T, Wynhoven B, Smaill F, Rouleau D, Gill J, Schlech W, Brumme ZL, Mo T, Gough K, Rachlis A, Harrigan PR, Walmsley SL |
2007 |
Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity. |
Eggink D, Huigen MC, Boucher CA, Götte M, Nijhuis M |
2007 |
Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine. |
Hantz O, Allaudeen HS, Ooka T, De Clercq E, Trepo C |
1984 |
Murine cytomegalovirus DNA polymerase: purification, characterization and role in the antiviral activity of acyclovir. |
Ochiai H, Kumura K, Minamishima Y |
1992 |
Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. |
Merta A, Votruba I, Rosenberg I, Otmar M, Hrebabecký H, Bernaerts R, Holý A |
1990 |
Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir. |
Kinchington PR, Araullo-Cruz T, Vergnes JP, Yates K, Gordon YJ |
2002 |
Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase. |
Taylor JL, Tom P, O'Brien WJ |
1998 |
Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir. |
Seifer M, Patty A, Serra I, Li B, Standring DN |
2009 |
Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TP. |
Murakami E, Ray AS, Schinazi RF, Anderson KS |
2004 |